Haemonetics Corp (HAE):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C2611)
◆英語タイトル:Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2611
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:56
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Haemonetics Corp (HAE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Braintree, Massachusetts, the US.

Haemonetics Corp Key Recent Developments

May 08,2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer
May 08,2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance
Feb 06,2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings
Jan 25,2018: Ellen M. Zane Rejoins Haemonetics Board of Directors
Oct 18,2017: Robert E. Abernathy Joins Haemonetics Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Haemonetics Corp – Key Facts 6
Haemonetics Corp – Key Employees 7
Haemonetics Corp – Key Employee Biographies 8
Haemonetics Corp – Major Products and Services 9
Haemonetics Corp – History 12
Haemonetics Corp – Company Statement 15
Haemonetics Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 – Company Analysis 20
Company Overview 20
Haemonetics Corp – Business Description 21
Product Category: Blood Center 21
Overview 21
Performance 21
Product Category: Cell Processing 22
Overview 22
Performance 22
Product Category: Hemostasis Management 22
Overview 22
Performance 22
Product Category: Plasma 23
Overview 23
Performance 23
Product Category: All Other 23
Performance 23
Product Category: EMEA 23
Performance 23
Product Category: Japan 24
Performance 24
Product Category: North America Plasma 24
Performance 24
Geographical Segment: Asia 24
Performance 24
Geographical Segment: Europe 24
Performance 24
Geographical Segment: Japan 24
Performance 24
Geographical Segment: Other 24
Performance 24
Geographical Segment: The US 25
Performance 25
Haemonetics Corp – Corporate Strategy 26
Haemonetics Corp – SWOT Analysis 27
SWOT Analysis – Overview 27
Haemonetics Corp – Strengths 27
Haemonetics Corp – Weaknesses 28
Haemonetics Corp – Opportunities 29
Haemonetics Corp – Threats 30
Haemonetics Corp – Key Competitors 31
Section 3 – Company Financial Ratios 32
Financial Ratios – Capital Market Ratios 32
Financial Ratios – Annual Ratios 33
Performance Chart 36
Financial Performance 36
Financial Ratios – Interim Ratios 37
Financial Ratios – Ratio Charts 38
Section 4 – Company’s Lifesciences Financial Deals and Alliances 39
Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Haemonetics Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40
Haemonetics Corp, Recent Deals Summary 41
Section 5 – Company’s Recent Developments 42
May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer 42
May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance 43
Feb 06, 2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings 45
Jan 25, 2018: Ellen M. Zane Rejoins Haemonetics Board of Directors 47
Oct 18, 2017: Robert E. Abernathy Joins Haemonetics Board of Directors 48
Jun 22, 2017: Haemonetics Announces Formation of Scientific Advisory Council 49
May 08, 2017: Haemonetics Reports 4th Quarter and Fiscal Year 2017 Results and Provides Fiscal 2018 Guidance 50
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
Haemonetics Corp, Key Facts 6
Haemonetics Corp, Key Employees 7
Haemonetics Corp, Key Employee Biographies 8
Haemonetics Corp, Major Products and Services 9
Haemonetics Corp, History 12
Haemonetics Corp, Other Locations 17
Haemonetics Corp, Subsidiaries 18
Haemonetics Corp, Key Competitors 31
Haemonetics Corp, Ratios based on current share price 32
Haemonetics Corp, Annual Ratios 33
Haemonetics Corp, Annual Ratios (Cont...1) 34
Haemonetics Corp, Annual Ratios (Cont...2) 35
Haemonetics Corp, Interim Ratios 37
Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Haemonetics Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 40
Haemonetics Corp, Recent Deals Summary 41
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55

List of Figures
Haemonetics Corp, Performance Chart (2014 - 2018) 36
Haemonetics Corp, Ratio Charts 38
Haemonetics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 39
Haemonetics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 40

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Haemonetics Corp (HAE):企業の財務・戦略的SWOT分析(Haemonetics Corp (HAE) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆